Skip to content

Utilization and its Impact on the Effects of Oral Anticoagulants using Japanese National Database of Health Insurance Claims.

Utilization and its Impact on the Effects of Oral Anticoagulants using Japanese National Database of Health Insurance Claims. - Utilization and its Impact on the Effects of Oral Anticoagulants.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000027974
Enrollment
400000
Registered
2017-07-01
Start date
2017-05-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

None listed

Sponsors

Nihon University School of Pharmacy.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with the first record of prescribing/dispensing of an oral anticoagulant after at least one-year of non-use.

Exclusion criteria

Exclusion criteria: 1.Patients younger than 20 years old when an anticoagulant was first prescribed. 2.Patients without diagnosis code of non-valvular AF. 3.Patients with diagnosis code of coagulation deficiency.

Design outcomes

Primary

MeasureTime frame
Hospitalization due to stroke, myocardial infarction, systemic embolism, or bleeding.

Countries

Japan

Contacts

Public ContactNobuhiro Ooba

Nihon University School of Pharmacy. Department of Clinical Pharmacy.

ooba.nobuhiro@nihon-u.ac.jp047-465-3548

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026